Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319006 · ClinicalTrials.gov registry record · Phase 1
Relative Bioavailability Study for GSK1278863A
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT01319006 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 30 participants.
The verdict
NCT01319006, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
A randomized, open-label, 3-period crossover study.
Interventions
- DRUG GSK1278863A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2011-02-25 |
| Est. Completion | 2011-04-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319006
The ClinicalTrials.gov registry entry for NCT01319006 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK1278863A is the first listed.
NCT01319006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319006 about?
NCT01319006 is a clinical study titled "Relative Bioavailability Study for GSK1278863A". A randomized, open-label, 3-period crossover study.
What is the current status of trial NCT01319006?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2011-02-25. Estimated completion is 2011-04-18.
What interventions are being tested in trial NCT01319006?
The interventions under investigation include: GSK1278863A (DRUG).
Who is sponsoring clinical trial NCT01319006?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.